Travere Therapeutics has partnered with Cincinnati Children's Hospital Medical Center (CCHMC) to offer a laboratory test that will help identify the presence and concentration levels of dihydroxy- and trihydroxycholestanoic acid (DHCA/THCA), atypical bile acids which can be hepatotoxic and may be associated with liver disease. This resource is provided at no cost to qualified patients, physicians, or payers.*
How to order the Atypical Bile Acid Test PROGRAM MATERIALS
Create your profile
(US physicians Only)
Order your folder containing program materials
The program materials will be delivered within 48 hours
Return completed serum sample and forms to CCHMC Laboratory
Receive results in approximately 2 weeks
ZELLWEGER SPECTRUM DISORDERS ATYPICAL BILE ACID SERUM TEST
*Log in for more information on eligibility for waiving the cost of the program.
Program may be canceled or changed at any time.